GPCR modulators therapy(Sosei Heptares/Lilly)

N/A

Report date: 2024/01/04 16:02:49

Base Information

Drug NameGPCR modulators therapy(Sosei Heptares/Lilly)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionG-protein coupled receptor modulators
TargetsG-protein coupled receptor
Therapy Area/IndicationsDiabetes MellitusMetabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And CompanyNxera Pharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEli Lilly And CompanyNxera Pharma Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes MellitusMetabolic Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A